Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

853 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

NCT05439629

Conditions
Eye Diseases, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, +2 more
Locations
  • Affiliated Hospital of Inner Mongolia Medical University Beijing, China
  • Beijing Chao Yang Hospital Beijing, China
  • Beijing Hospital Beijing, China
  • China-Japan Friendship Hospital Beijing, China
View all 48 locations
View Trial Details
Completed

Repository for Inherited Eye Diseases

NCT00378742

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Ranibizumab and Reduced Fluence PDT for AMD

NCT00527475

Conditions
Eye Diseases, Macular Degeneration, Metaplasia, +5 more
Locations
  • California Retina Consultants & Research Foundation Santa Barbara, California, United States
  • Associated Retinal Consultants Ann Arbor, Michigan, United States
  • Texas Retina Associates Arlington, Texas, United States
View Trial Details
Completed

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)

NCT05919693

Conditions
Diabetic Macular Edema (DME), Eye Diseases, Macular Degeneration, +3 more
Locations
  • Phoenix, AZ Phoenix, Arizona, United States
  • Bakersfield, CA Bakersfield, California, United States
  • Modesto, CA Modesto, California, United States
  • Mountain View, CA Mountain View, California, United States
View all 32 locations
View Trial Details
Completed

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

NCT02462889

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
  • NJ Retina Edison, New Jersey, United States
  • Retina Consultants of Houston Houston, Texas, United States
View Trial Details
Completed

Phase 2/3 Study of ALK-001 in Geographic Atrophy

NCT03845582

Conditions
AMD, Age Related Macular Degeneration, Atrophy, Geographic, +5 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Beverly Hills, California, United States
  • Alkeus Site Lakewood, Colorado, United States
  • Alkeus Site Clearwater, Florida, United States
View all 24 locations
View Trial Details
Completed

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

NCT04435366

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
  • Eye Medical Center of Fresno Fresno, California, United States
  • Retina Consultants of Orange County Fullerton, California, United States
View all 205 locations
View Trial Details

Related conditions